vs
Side-by-side financial comparison of Bank First Corp (BFC) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
Bank First Corp is the larger business by last-quarter revenue ($44.9M vs $39.6M, roughly 1.1× SBC Medical Group Holdings Inc). Bank First Corp runs the higher net margin — 45.8% vs 35.9%, a 9.9% gap on every dollar of revenue. On growth, Bank First Corp posted the faster year-over-year revenue change (12.1% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $51.0M). Over the past eight quarters, Bank First Corp's revenue compounded faster (9.1% CAGR vs -15.0%).
First Horizon Corporation, formerly First Tennessee Bank, is a financial services company, founded in 1864, and based in Memphis, Tennessee. Through its banking subsidiary First Horizon Bank, it provides financial services through locations in 12 states across the Southeast, a region in which it is the fourth largest regional bank.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
BFC vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $39.6M |
| Net Profit | $18.4M | $14.2M |
| Gross Margin | — | 73.1% |
| Operating Margin | 51.0% | 32.5% |
| Net Margin | 45.8% | 35.9% |
| Revenue YoY | 12.1% | -10.9% |
| Net Profit YoY | 4.8% | 117.2% |
| EPS (diluted) | $1.87 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $39.6M | ||
| Q3 25 | $44.2M | $43.4M | ||
| Q2 25 | $41.6M | $43.4M | ||
| Q1 25 | $43.1M | $47.3M | ||
| Q4 24 | $40.1M | $44.4M | ||
| Q3 24 | $40.8M | $53.1M | ||
| Q2 24 | $38.9M | $53.1M | ||
| Q1 24 | $37.7M | $54.8M |
| Q4 25 | $18.4M | $14.2M | ||
| Q3 25 | $18.0M | $12.8M | ||
| Q2 25 | $16.9M | $2.5M | ||
| Q1 25 | $18.2M | $21.5M | ||
| Q4 24 | $17.5M | $6.5M | ||
| Q3 24 | $16.6M | $2.8M | ||
| Q2 24 | $16.1M | $18.5M | ||
| Q1 24 | $15.4M | $18.8M |
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 81.5% | ||
| Q2 24 | — | 74.2% | ||
| Q1 24 | — | 72.1% |
| Q4 25 | 51.0% | 32.5% | ||
| Q3 25 | 50.8% | 36.6% | ||
| Q2 25 | 49.7% | 33.6% | ||
| Q1 25 | 51.3% | 51.1% | ||
| Q4 24 | 54.4% | 10.6% | ||
| Q3 24 | 50.7% | 26.1% | ||
| Q2 24 | 51.0% | 51.4% | ||
| Q1 24 | 45.6% | 44.6% |
| Q4 25 | 45.8% | 35.9% | ||
| Q3 25 | 40.7% | 29.6% | ||
| Q2 25 | 40.5% | 5.7% | ||
| Q1 25 | 42.3% | 45.4% | ||
| Q4 24 | 49.3% | 14.7% | ||
| Q3 24 | 40.6% | 5.3% | ||
| Q2 24 | 41.3% | 34.8% | ||
| Q1 24 | 40.8% | 34.2% |
| Q4 25 | $1.87 | $0.15 | ||
| Q3 25 | $1.83 | $0.12 | ||
| Q2 25 | $1.71 | $0.02 | ||
| Q1 25 | $1.82 | $0.21 | ||
| Q4 24 | $1.75 | $0.05 | ||
| Q3 24 | $1.65 | $0.03 | ||
| Q2 24 | $1.59 | $0.20 | ||
| Q1 24 | $1.51 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $243.2M | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $643.8M | $248.3M |
| Total Assets | $4.5B | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $243.2M | $164.1M | ||
| Q3 25 | $126.2M | $127.4M | ||
| Q2 25 | $120.3M | $152.7M | ||
| Q1 25 | $300.9M | $132.1M | ||
| Q4 24 | $261.3M | $125.0M | ||
| Q3 24 | $204.4M | $137.4M | ||
| Q2 24 | $99.0M | — | ||
| Q1 24 | $83.4M | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $643.8M | $248.3M | ||
| Q3 25 | $628.1M | $248.0M | ||
| Q2 25 | $612.3M | $244.6M | ||
| Q1 25 | $648.4M | $226.4M | ||
| Q4 24 | $639.7M | $195.1M | ||
| Q3 24 | $628.9M | $205.0M | ||
| Q2 24 | $614.6M | $8.8M | ||
| Q1 24 | $609.3M | $9.0M |
| Q4 25 | $4.5B | $380.4M | ||
| Q3 25 | $4.4B | $321.4M | ||
| Q2 25 | $4.4B | $315.3M | ||
| Q1 25 | $4.5B | $284.6M | ||
| Q4 24 | $4.5B | $266.1M | ||
| Q3 24 | $4.3B | $296.5M | ||
| Q2 24 | $4.1B | $19.5M | ||
| Q1 24 | $4.1B | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $62.5M | $52.0M |
| Free Cash FlowOCF − Capex | $51.0M | $51.2M |
| FCF MarginFCF / Revenue | 113.6% | 129.3% |
| Capex IntensityCapex / Revenue | 25.5% | 2.0% |
| Cash ConversionOCF / Net Profit | 3.40× | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $75.8M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $62.5M | $52.0M | ||
| Q3 25 | $15.5M | $-20.9M | ||
| Q2 25 | $11.9M | $-8.3M | ||
| Q1 25 | $6.2M | $1.9M | ||
| Q4 24 | $65.8M | $-7.3M | ||
| Q3 24 | $18.8M | $5.0M | ||
| Q2 24 | $14.9M | $19.2M | ||
| Q1 24 | $1.3M | $3.7M |
| Q4 25 | $51.0M | $51.2M | ||
| Q3 25 | $12.5M | $-20.9M | ||
| Q2 25 | $8.2M | $-8.6M | ||
| Q1 25 | $4.0M | $1.7M | ||
| Q4 24 | $58.6M | $-7.9M | ||
| Q3 24 | $16.9M | $4.6M | ||
| Q2 24 | $13.7M | $18.3M | ||
| Q1 24 | $551.0K | $3.0M |
| Q4 25 | 113.6% | 129.3% | ||
| Q3 25 | 28.2% | -48.3% | ||
| Q2 25 | 19.8% | -19.9% | ||
| Q1 25 | 9.3% | 3.5% | ||
| Q4 24 | 146.3% | -17.8% | ||
| Q3 24 | 41.5% | 8.7% | ||
| Q2 24 | 35.3% | 34.5% | ||
| Q1 24 | 1.5% | 5.4% |
| Q4 25 | 25.5% | 2.0% | ||
| Q3 25 | 6.7% | 0.1% | ||
| Q2 25 | 8.7% | 0.7% | ||
| Q1 25 | 5.0% | 0.5% | ||
| Q4 24 | 18.0% | 1.3% | ||
| Q3 24 | 4.5% | 0.8% | ||
| Q2 24 | 3.1% | 1.6% | ||
| Q1 24 | 2.1% | 1.3% |
| Q4 25 | 3.40× | 3.66× | ||
| Q3 25 | 0.86× | -1.63× | ||
| Q2 25 | 0.70× | -3.39× | ||
| Q1 25 | 0.34× | 0.09× | ||
| Q4 24 | 3.75× | -1.12× | ||
| Q3 24 | 1.13× | 1.77× | ||
| Q2 24 | 0.93× | 1.04× | ||
| Q1 24 | 0.09× | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BFC
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
